Skip to main content
AAPS Open

Table 5 Initial and updated risk assessment of the formulation

From: Gamma oryzanol niosomal gel for skin cancer: formulation and optimization using quality by design (QbD) approach

  1. The factors with *Low category have been converted to low risk from high or medium risk
Back to article page